paraoxon has been researched along with Diabetes Mellitus, Adult-Onset in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carradori, S; Mahomoodally, MF; Mollica, A; Picot, MCN; Stefanucci, A; Zengin, G | 1 |
| Graessler, J; Kopprasch, S; Kuhlisch, E; Pietzsch, J | 1 |
| Berthezene, F; Cao, H; Girard-Globa, A; Moulin, P | 1 |
| Gavella, M; Lipovac, V; Mrzljak, V; Reiner, E; Simeon-Rudolf, V; Svedruzic, D | 1 |
4 other study(ies) available for paraoxon and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
In vitro and in silico Studies of Mangiferin from Aphloia theiformis on Key Enzymes Linked to Diabetes Type 2 and Associated Complications.
Topics: Allosteric Site; Animals; Catalytic Domain; Diabetes Mellitus, Type 2; Fabaceae; Glycogen Phosphorylase; Humans; Hydrogen Bonding; Hydrolases; Kinetics; Molecular Docking Simulation; Paraoxon; Swine; Tracheophyta; Xanthones | 2017 |
Lack of association between serum paraoxonase 1 activities and increased oxidized low-density lipoprotein levels in impaired glucose tolerance and newly diagnosed diabetes mellitus.
Topics: Adult; Aged; Aryldialkylphosphatase; C-Peptide; Diabetes Mellitus, Type 2; Esterases; Female; Glucose Intolerance; Glycated Hemoglobin; Homeostasis; Humans; Insulin; Lipoproteins, LDL; Male; Middle Aged; Paraoxon; Phenotype; Phenylacetates; Substrate Specificity | 2003 |
Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q-->R genetic polymorphism.
Topics: Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Copper; Diabetes Mellitus, Type 2; Esterases; Female; Genotype; Humans; In Vitro Techniques; Lipid Peroxidation; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Paraoxon; Polymorphism, Genetic | 1999 |
Paraoxonase and arylesterase activities in the serum of two hyperlipoproteinaemic patients after repeated extracorporal lipid precipitation.
Topics: Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Chelating Agents; Chemical Precipitation; Diabetes Mellitus, Type 2; Edetic Acid; Esterases; Extracorporeal Circulation; Heparin; Humans; Hyperlipoproteinemias; Lipids; Paraoxon; Phenylacetates; Renal Dialysis; Substrate Specificity | 1999 |